Speakers
Priti Krishtel | I-MAK, Co-Founder and Co-Executive Director priti@i-mak.org |
Genia Long | Analysis Group, Senior Advisor genia.long@analysisgroup.com |
Ed Silverman | STAT, Pharmalot Columnist ed.silverman@statnews.com |
Experts and analysts
Joseph Antos | American Enterprise Institute, Wilson H. Taylor Scholar in Health Care and Retirement Policy jantos@aei.org 202-862-5983 |
Peter Barton Hutt | Covington & Burling LLP, Senior Counsel; Harvard Law School, Lecturer on Food and Drug Law phutt@cov.com 202-662-5522 |
Michael A. Carrier | Rutgers Law School, Distinguished Professor of Law; Rutgers Institute for Information Policy and Law, Co-Director mcarrier@camlaw.rutgers.edu 856-225-6380 |
Rena Conti | Boston University Institute for Health System Innovation & Policy, Associate Research Director of Biopharma & Public Policy rconti@bu.edu |
Henry G. Grabowski | Duke University, Professor Emeritus of Economics grabow@econ.duke.edu |
Doug Holtz-Eakin | American Action Forum, President dholtzeakin@americanactionforum.org |
Ameet Sarpatwari | Harvard Medical School, Instructor in Medicine; Brigham Women’s Hospital, Assistant Director of the Program on Regulation, Therapeutics, and Law in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine asarpatwari@bwh.harvard.edu |
Jeremy Sharp | Waxman Strategies, Senior Vice President jeremy@waxmanstrategies.com 202-684-8237 |
Government
Anna Abram | Food and Drug Administration, Deputy Commissioner for Policy, Planning, Legislation and Analysis anna.abram@fda.hhs.gov |
Elizabeth Jex | Federal Trade Commission, Attorney Advisor for the Office of Policy Planning ejex@ftc.gov |
Stakeholders
Lauren Aronson | Campaign for Sustainable Rx Pricing, Executive Director laronson@mc-dc.com 202-585-0255 |
Andrew Barnhill | GlaxoSmithKline, Director of Federal Policy and HHS Strategy andrew.t.barnhill@gsk.com |
Kristin Bass | Pharmaceutical Care Management Association, Chief Policy and External Affairs Officer kbass@pcmanet.org 202-756-5700 |
Adam J. Fein | Drug Channels Institute, Chief Executive Officer afein@pembrokeconsulting.com 215-523-5700 |
Jennifer Jones | Blue Cross Blue Shield Association, Legislative and Regulatory Policy Director jennifer.jones@bcbsa.com |
Erik Komendant | Association for Accessible Medicines, Vice President of Federal Affairs Erik.Komendant@accessiblemeds.org |
David Mitchell | Patients for Affordable Drugs, President and Founder david@patientsforaffordabledrugs.org |
Leigh Purvis | AARP Health Policy Institute, Director of Health Services Research lpurvis@aarp.org 202-434-3890 |
Andrew Rosenberg | The Biosimilars Forum, Executive Director arosenberg@thornrun.com 202-688-0223 |
Sylvia Trujillo | American Medical Association, Senior Washington Counsel
slyvia.trujillo@ama-assn.org 202-789-7481 |
Polly Webster | Kaiser Permanente, Senior Policy Advisor |
Tom Wilbur | Pharmaceutical Research and Manufacturers of America, Director of Public Affairs twilbur@phrma.org 202-835-3400 |
The Alliance for Health Policy gratefully acknowledges the support of the National Institute of Health Care Management (NIHCM) Foundation and the Association of Health Care Journalists (AHCJ) for this event.